BackVascular Biogenics Overview

Vascular Biogenics Total Assets

Vascular Biogenics's total assets is $11M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$11.00M
↓ 55.35% YoYΔ $-13.64M vs prior year quarter

Peer average

Loading

Vascular Biogenics Total Assets History

Loading

Vascular Biogenics vs. peers: Total Assets Comparison

Loading

Vascular Biogenics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Vascular Biogenics (VBLT) FAQ

The latest total assets for VBLT is $11M as of June 2024. That compares with $25M in the prior-year period — down 55.4% year over year. Investors often review this figure alongside Vascular Biogenics's historical trend and sector peers before judging valuation or financial health.

Over the past year, VBLT's total assets moved from $25M to $11M — a 55.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vascular Biogenics's operating scale or balance-sheet position.

A total assets figure of $11M for VBLT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting VBLT's total assets ($11M), review year-over-year change from $25M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Vascular Biogenics's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.